Antihypertensive Drugs in Pregnancy
On this page
Direct answer
Antihypertensive drugs in pregnancy are chosen from labetalol, nifedipine and methyldopa for long-term control, with hydralazine or intravenous labetalol reserved for acute severe hypertension. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are contraindicated because they cause fetotoxicity, including oligohydramnios, renal dysgenesis and skull hypoplasia. Atenolol is avoided because it is linked with fetal growth restriction, so the choice also depends on the woman's asthma and cardiac status.
What you must remember
- First-line oral agents: labetalol, extended-release nifedipine and methyldopa have the longest experience in pregnancy.
- Acute severe hypertension: intravenous labetalol or intravenous hydralazine, with oral immediate-release nifedipine as an alternative.
- Contraindicated: ACE inhibitors, angiotensin receptor blockers and direct renin inhibitors, because of fetotoxicity and neonatal renal failure.
- Avoid atenolol: it is associated with intrauterine growth restriction.
- Labetalol caution: avoided in bronchial asthma, heart block and decompensated heart failure because of beta-blockade.
- Methyldopa effects: sedation, depression and haemolytic anaemia with a positive direct Coombs test.
Matching drug to indication
Antihypertensive choice in pregnancy follows the clinical setting, not habit. The table lists the main agents, their role and the caution that most often appears in questions.
| Drug | Role in pregnancy | Key caution |
|---|---|---|
| Labetalol | First-line oral and intravenous | Avoid in asthma and heart block |
| Nifedipine | First-line oral; acute oral option | Headache, flushing, tachycardia |
| Methyldopa | Long-standing oral first line | Depression, haemolysis, positive Coombs |
| Hydralazine | Acute intravenous rescue | Reflex tachycardia, headache |
| ACE inhibitor or ARB | Contraindicated | Oligohydramnios, renal dysgenesis |
Any woman on an ACE inhibitor or ARB needs a switch to a pregnancy-compatible drug once pregnancy is recognised. Acute treatment choice also depends on heart rate and the availability of intravenous monitoring.
Labetalol and nifedipine are the usual first choices for most women, while methyldopa remains the option where the others are unsuitable. Blood pressure targets are set to avoid both maternal stroke and reduced placental perfusion. Examiners also test the fetal toxicity timeline, since ACE inhibitor harm is linked mainly with exposure in the second and third trimesters.
Where the exam tries to catch you
Questions in this area test contraindications and the situations in which a drug is avoided.
- Trap: Continuing an ACE inhibitor until the second trimester because it is well tolerated. Correct: Stop it as soon as pregnancy is identified or planned, and switch to a compatible drug.
- Trap: Choosing atenolol as a cheap beta-blocker. Correct: Atenolol is linked with growth restriction; labetalol is the preferred beta-blocker.
- Trap: Starting a diuretic routinely in pre-eclampsia. Correct: Diuretics are usually avoided in pre-eclampsia because plasma volume is already reduced; they may be continued in chronic hypertension if already taken.
Frequently asked questions
Why are ACE inhibitors contraindicated in pregnancy?
ACE inhibitors and angiotensin receptor blockers disrupt the fetal renin-angiotensin system. Exposure in the second and third trimesters is linked with oligohydramnios, fetal renal dysgenesis and skull hypoplasia. Antihypertensive drugs in pregnancy therefore have to be stopped and replaced once pregnancy is recognised.
Which antihypertensive is used for an acute severe hypertensive crisis in pregnancy?
Intravenous labetalol and intravenous hydralazine are the standard acute agents, with oral immediate-release nifedipine as an option. Blood pressure is lowered gradually to avoid reducing fetal perfusion. The acute choice depends on heart rate, asthma status and the monitoring available.
Is methyldopa safe to use in pregnancy?
Methyldopa has one of the longest safety records among antihypertensives used in pregnancy. Its adverse effects include sedation, depression and haemolytic anaemia with a positive direct Coombs test. Methyldopa is chosen with awareness of these effects, not dismissed.
Can labetalol be used in a woman with bronchial asthma?
Labetalol is generally avoided in women with bronchial asthma because its beta-blockade can precipitate bronchospasm. Nifedipine or methyldopa is usually preferred in that situation. The final choice rests with the treating obstetrician and physician after review of asthma control.